Unraveling the Structure of Meclizine Dihydrochloride with MicroED.
Jieye LinJohan UngeTamir GonenPublished in: bioRxiv : the preprint server for biology (2023)
Meclizine (Antivert, Bonine) is a first-generation H1 antihistamine used in the treatment of motion sickness and vertigo. Despite its wide medical use for over 70 years, its crystal structure and the details of protein-drug interactions remained unknown. In this study, we used microcrystal electron diffraction (MicroED) to determine the three-dimensional (3D) crystal structure of meclizine dihydrochloride directly from a seemingly amorphous powder. Two racemic enantiomers (R/S) were found in the unit cell, which packed as repetitive double layers in the crystal lattice. The packing was made of multiple strong N-H···Cl - hydrogen bonding interactions and weak interactions like C-H···Cl - and pi-stacking. Molecular docking revealed the binding mechanism of meclizine to the histamine H1 receptor. A comparison of the docking complexes between histamine H1 receptor and meclizine or levocetirizine (a second-generation antihistamine) showed the conserved binding sites. This research illustrates the combined use of MicroED and molecular docking in unraveling protein-drug interactions for precision drug design and optimization.
Keyphrases
- molecular docking
- crystal structure
- molecular dynamics simulations
- protein protein
- binding protein
- single cell
- healthcare
- amino acid
- small molecule
- high frequency
- molecular dynamics
- transcription factor
- emergency department
- stem cells
- room temperature
- high speed
- drug induced
- solar cells
- solid state
- high resolution
- combination therapy
- capillary electrophoresis
- ionic liquid